Friday, August 21, 2026

TOPICS

Home Tags Fourth quarter earnings

Tag: fourth quarter earnings

CITIZENS FINANCIAL Group Inc. reported a profit of $1.61 billion in 2023, a decrease from $2.1 billion a year earlie. / COURTESY HORVATH & TREMBLAY

Citizens Financial’s profit drops 22% for 2023 to $1.61B

PROVIDENCE – Citizens Financial Group Inc.'s annual profit fell 22% to $1.61 billion in 2023 compared with a year earlier as the rising cost...
BANK OF AMERICA Corp. saw its fourth-quarter profit fall more than 50% from a year earlier because of lingering banking industry headwinds. / AP FILE PHOTO/MICHAEL DWYER

Bank of America profits fall 50% in fourth quarter of 2023

NEW YORK (AP) – Bank of America Corp. saw its fourth-quarter profit fall more than 50% from a year earlier as the banking industry...

General Dynamics reports $3.4B profit in 2022

PROVIDENCE – General Dynamics Corp. on Wednesday reported a profit of $3.4 billion for 2022, a 4.1% increase year over year.  Earnings of $12.19 per...
RAYTHEON TECHNOLOGIES CORP. on Tuesday reported fourth-quarter profit of $1.42 billion and and announced its plan to realign its business units into three segments.

Raytheon reports $5.2B profit in 2022, announces realignment of businesses

ARLINGTON, Va. – Raytheon Technologies Corp. on Tuesday reported a year-end profit of $5.2 billion in 2022, or $3.50 per share, and announced its...

Bank of America profits rise; bank warns of slowing economy

NEW YORK (AP) – Bank of America's fourth-quarter profits rose slightly from a year ago, as higher credit costs and potentially bad loans more...

UNFI reports $248M profit in fiscal 2022

PROVIDENCE – United Natural Foods Inc. earned a profit of $248 million for its fiscal year that ended July 31, or $4.07 per share,...

AstroNova posts $6.4M profit in FY 2022

WEST WARWICK – AstroNova Inc. posted a net income of $6.4 million for its fiscal year 2022 ended Jan. 31, or 89 cents per...

Rubius Therapeutics reports $196.5M loss in 2021

PROVIDENCE – Rubius Therapeutics Inc. on Friday reported a loss of $196.5 million in 2021, or $2.23 per diluted share.  The clinical-stage biopharmaceutical company, which...
- Featured Event -

Latest News